The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 31 unusual trades. Delving into the details, we found 51% of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback